Disclaimer PubMed and NLM

2023 January 21
1.
Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system. Grüter T, Mohamad N, Rilke N, Blusch A, Sgodzai M, Demir S, Pedreiturria X, Lemhoefer K, Gisevius B, Haghikia A, Fisse AL, Motte J, Gold R, Pitarokoili K.
Proc Natl Acad Sci U S A. 2023 Jan 24;120(4):e2216941120. doi: 10.1073/pnas.2216941120. Epub 2023 Jan 20.
PMID: 36669102
2.
1,2-13C2-Glucose Tracing Approach to Assess Metabolic Alterations of Human Monocytes under Neuroinflammatory Conditions. Giacomello G, Otto C, Priller J, Ruprecht K, Böttcher C, Parr MK.
Curr Issues Mol Biol. 2023 Jan 16;45(1):765-781. doi: 10.3390/cimb45010051.
PMID: 36661537
3.
A Case Series of Trigeminal Neuralgia With Pure Venous Compression: Postoperative Outcomes Associated With Intraoperative Venous Transposition Versus Coagulation. So RJ, Kalluri AL, Materi J, Nair SK, Lim M, Huang J, Bettegowda C, Xu R.
Oper Neurosurg (Hagerstown). 2022 Dec 12. doi: 10.1227/ons.0000000000000546. Online ahead of print.
PMID: 36661381
4.
Editorial for “Deep Learning for Non-Invasive Assessment of H3 K27M Mutation Status in Diffuse Midline Gliomas Using MR Imaging”. Bonacchi R, De Meo E.
J Magn Reson Imaging. 2023 Jan 20. doi: 10.1002/jmri.28615. Online ahead of print.
PMID: 36661197 No abstract available.
5.
Methods for Brain Atrophy MR Quantification in Multiple Sclerosis: Application to the Multicenter INNI Dataset. Storelli L, Pagani E, Pantano P, Piervincenzi C, Tedeschi G, Gallo A, De Stefano N, Battaglini M, Rocca MA, Filippi M; INNI Network.
J Magn Reson Imaging. 2023 Jan 20. doi: 10.1002/jmri.28616. Online ahead of print.
PMID: 36661195
6.
The emerging role of focal muscle vibration in rehabilitation of neurological disorders. Tahir S, Baig MO, Rathore FA, Aslam H.
J Pak Med Assoc. 2022 Oct;72(10):2126-2128. doi: 10.47391/JPMA.22-106.
PMID: 36661016
7.
Additional advances related to the health benefits associated with kombucha consumption. Esatbeyoglu T, Sarikaya Aydin S, Gültekin Subasi B, Erskine E, Gök R, Ibrahim SA, Yilmaz B, Özogul F, Capanoglu E.
Crit Rev Food Sci Nutr. 2023 Jan 20:1-18. doi: 10.1080/10408398.2022.2163373. Online ahead of print.
PMID: 36660921
8.
[Pharmacotherapy: New drugs and vaccines in 2022]. Haefliger D, Livio F.
Rev Med Suisse. 2023 Jan 18;19(N° 809-10):66-73. doi: 10.53738/REVMED.2023.19.809-10.66.
PMID: 36660841 French.
9.
[Neurology: what’s new in 2022]. Bouvy C, Caranzano L, Allali G, Bally J, Benninger D, Beuchat I, Castro Jimenez M, Di Virgilio G, Hirt L, Michel P, Novy J, Pot Kreis C, Rossetti A, Rouaud O, Ryvlin P, Salvioni Chiabotti P, Sokolov A, Strambo D, Théaudin M, Du Pasquier R.
Rev Med Suisse. 2023 Jan 18;19(N° 809-10):42-45. doi: 10.53738/REVMED.2023.19.809-10.42.
PMID: 36660836 French.
10.
Immunoglobulin GM (γ marker) genes as effect modifiers of Epstein-Barr virus-multiple sclerosis association. Pandey JP.
Immunology. 2023 Jan 19. doi: 10.1111/imm.13625. Online ahead of print.
PMID: 36659869 No abstract available.
11.
RNA-binding proteins in autoimmunity: From genetics to molecular biology. Lodde V, Floris M, Zoroddu E, Zarbo IR, Idda ML.
Wiley Interdiscip Rev RNA. 2023 Jan 19:e1772. doi: 10.1002/wrna.1772. Online ahead of print.
PMID: 36658783 Review.
2023 January 08
1.
Teriflunomide as a therapeutic means for myelin repair. Göttle P, Groh J, Reiche L, Gruchot J, Rychlik N, Werner L, Samper Agrelo I, Akkermann R, Zink A, Prigione A, Hartung HP, Martini R, Küry P.
J Neuroinflammation. 2023 Jan 7;20(1):7. doi: 10.1186/s12974-022-02686-6.
PMID: 36611185
2.
Utility of the tibial nerve somatosensory evoked potentials in differentiating between neuromyelitis optica spectrum disorders and multiple sclerosis. Kanbayashi T, Ogawa G, Ito T, Hokkoku K, Oishi C, Hatanaka Y, Sonoo M.
Mult Scler Relat Disord. 2023 Jan 3;70:104503. doi: 10.1016/j.msard.2023.104503. Online ahead of print.
PMID: 36610361
3.
Factors associated with the misdiagnosis of neuromyelitis optica spectrum disorder. Smith AD, Moog TM, Burgess KW, McCreary M, Okuda DT.
Mult Scler Relat Disord. 2023 Jan 2;70:104498. doi: 10.1016/j.msard.2023.104498. Online ahead of print.
PMID: 36610360
4.
Estimated prevalence of AQP4 positive neuromyelitis optica spectrum disorder and MOG antibody associated disease in São Paulo, Brazil. Silva GD, Apóstolos-Pereira SL, Callegaro D.
Mult Scler Relat Disord. 2022 Dec 23;70:104488. doi: 10.1016/j.msard.2022.104488. Online ahead of print.
PMID: 36610359
5.
Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases. Bai X, Bian Z, Zhang M.
Phytomedicine. 2022 Nov 30;109:154582. doi: 10.1016/j.phymed.2022.154582. Online ahead of print.
PMID: 36610130 Review.
6.
Effects of multi-task training on motor and cognitive performances in multiple sclerosis patients without clinical disability: a single-blinded randomized controlled trial. Ozkul C, Eldemir K, Apaydin Y, Gulsen C, Irkec C, Guclu-Gunduz A.
Acta Neurol Belg. 2023 Jan 7. doi: 10.1007/s13760-023-02172-7. Online ahead of print.
PMID: 36609834
7.
Challenging diagnosis and treatment decision of a long-history autoantibody-negative autoimmune encephalitis: Expert commentary. Abboud H.
Parkinsonism Relat Disord. 2023 Jan 2:105278. doi: 10.1016/j.parkreldis.2023.105278. Online ahead of print.
PMID: 36609094 No abstract available.
8.
Antigen-independent IL-17A production by bystander-activated CD4+IL-1R1+ cells in patients with multiple sclerosis. Yeon Kim S, Kim Y, Kim SH, Han SM, Park H, May Payumo R, Eun Kim H, Hyun JW, Hoon Kim K, Lee EJ, Jin Kim H.
Hum Immunol. 2023 Jan 4:S0198-8859(22)00253-1. doi: 10.1016/j.humimm.2022.12.004. Online ahead of print.
PMID: 36609052
9.
Molecular biomarkers and cognitive impairment in multiple sclerosis: state of the field, limitations, and future direction – A systematic review and meta-analysis. Rademacher TD, Meuth SG, Wiendl H, Johnen A, Landmeyer NC.
Neurosci Biobehav Rev. 2023 Jan 3:105035. doi: 10.1016/j.neubiorev.2023.105035. Online ahead of print.
PMID: 36608917 Review.
10.
Fractalkine enhances oligodendrocyte regeneration and remyelination in a demyelination mouse model. de Almeida MMA, Watson AES, Bibi S, Dittmann NL, Goodkey K, Sharafodinzadeh P, Galleguillos D, Nakhaei-Nejad M, Kosaraju J, Steinberg N, Wang BS, Footz T, Giuliani F, Wang J, Sipione S, Edgar JM, Voronova A.
Stem Cell Reports. 2022 Dec 27:S2213-6711(22)00590-2. doi: 10.1016/j.stemcr.2022.12.001. Online ahead of print.
PMID: 36608690
2022 December 03
1.
Economic burden of multiple sclerosis in Slovakia – from 2015 to 2020. Babela R, Dugas J.
BMC Health Serv Res. 2022 Dec 2;22(1):1467. doi: 10.1186/s12913-022-08883-6.
PMID: 36461018
2.
Immunosuppressive biomaterial-based therapeutic vaccine to treat multiple sclerosis via re-establishing immune tolerance. Nguyen TL, Choi Y, Im J, Shin H, Phan NM, Kim MK, Choi SW, Kim J.
Nat Commun. 2022 Dec 2;13(1):7449. doi: 10.1038/s41467-022-35263-9.
PMID: 36460677
3.
A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Almenara-Fuentes L, Rodriguez-Fernandez S, Rosell-Mases E, Kachler K, You A, Salvado M, Andreev D, Steffen U, Bang H, Bozec A, Schett G, Le Panse R, Verdaguer J, Dalmases M, Rodriguez-Vidal S, Barneda-Zahonero B, Vives-Pi M.
Nanomedicine. 2022 Dec 5:102635. doi: 10.1016/j.nano.2022.102635. Online ahead of print.
PMID: 36481472
4.
Key role of the gut-microbiota-brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain. Wang X, Eguchi A, Yang Y, Chang L, Wan X, Shan J, Qu Y, Ma L, Mori C, Yang J, Hashimoto K.
Neurobiol Dis. 2022 Dec 6:105951. doi: 10.1016/j.nbd.2022.105951. Online ahead of print.
PMID: 36493975
5.
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study. Gastaldi M, Foiadelli T, Greco G, Scaranzin S, Rigoni E, Masciocchi S, Ferrari S, Mancinelli C, Brambilla L, Mancardi M, Giacomini T, Ferraro D, Della Corte M, Gallo A, Di Filippo M, Benedetti L, Novi G, Versino M, Banfi P, Iorio R, Moiola L, Turco E, Sartori S, Nosadini M, Ruggieri M, Savasta S, Colombo E, Ballante E, Jarius S, Mariotto S, Franciotta D; NINA study group.
J Neurol Neurosurg Psychiatry. 2022 Dec 2:jnnp-2022-330237. doi: 10.1136/jnnp-2022-330237. Online ahead of print.
PMID: 36460438
6.
The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemic. Murgia F, Fiamma M, Serra S, Marras G, Argiolas R, Mattana C, Mattu MG, Garau MC, Doneddu S, Olla S, Cocco E, Lorefice L, Muntoni S, Paffi P, Porru S, Abis M, Bellizzi S, Pani A, Angioi A, Simbula G, Mussap M, Massidda O, Carta F, Atzori L.
Clin Exp Med. 2022 Dec 2. doi: 10.1007/s10238-022-00959-1. Online ahead of print.
PMID: 36459278
7.
Comprehensive Investigations Relationship Between Viral Infections and Multiple Sclerosis Pathogenesis. Sedighi S, Gholizadeh O, Yasamineh S, Akbarzadeh S, Amini P, Favakehi P, Afkhami H, Firouzi-Amandi A, Pahlevan D, Eslami M, Yousefi B, Poortahmasebi V, Dadashpour M.
Curr Microbiol. 2022 Dec 2;80(1):15. doi: 10.1007/s00284-022-03112-z.
PMID: 36459252 Free PMC article. Review.
8.
Possible role of the NLRP3 inflammasome and the gut-brain axis in multiple sclerosis-related depression. Maciak K, Dziedzic A, Saluk J.
FASEB J. 2023 Jan;37(1):e22687. doi: 10.1096/fj.202201348R.
PMID: 36459154 Review.
9.
Escape, expand, embrace: the transformational lived experience of rediscovering the self and the other while dancing with Parkinson’s or Multiple Sclerosis. Carapellotti AM, Meijerink HJEM, Gravemaker-Scott C, Thielman L, Kool R, Lewin N, Abma TA.
Int J Qual Stud Health Well-being. 2023 Dec;18(1):2143611. doi: 10.1080/17482631.2022.2143611.
PMID: 36458742
10.
Energy expenditure and perceived effort during uphill and downhill walking in people with multiple sclerosis. Har-Nir I, Frid L, Kalron A.
Eur J Phys Rehabil Med. 2022 Dec 2. doi: 10.23736/S1973-9087.22.07682-1. Online ahead of print.
PMID: 36458477
11.
The importance of neuromuscular rate of force development for physical function in aging and common neurodegenerative disorders – a systematic review. Lomborg SD, Dalgas U, Hvid LG.
J Musculoskelet Neuronal Interact. 2022 Dec 1;22(4):562-586.
PMID: 36458393 Review.
12.
Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis. Esposito M, De Berardinis A, Totaro R, Fargnoli MC.
JAAD Case Rep. 2022 Nov 5;31:1-5. doi: 10.1016/j.jdcr.2022.10.031. eCollection 2023 Jan.
PMID: 36458235 Free PMC article. No abstract available.
13.
Corrigendum: Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial. Rahimlou M, Nematollahi S, Husain D, Banaei-Jahromi N, Majdinasab N, Hosseini SA.
Front Neurosci. 2022 Nov 15;16:1085572. doi: 10.3389/fnins.2022.1085572. eCollection 2022.
PMID: 36458042 Free PMC article.
14.
Multiple sclerosis and obesity: The role of adipokines. Correale J, Marrodan M.
Front Immunol. 2022 Nov 15;13:1038393. doi: 10.3389/fimmu.2022.1038393. eCollection 2022.
PMID: 36457996 Free PMC article. Review.
15.
The Effect of Sialic Acid on MiR-320a and Let-7e Expression in Human Glial Cell Line. Noorbakhsh N, Galehdari H, Shafiei M.
Basic Clin Neurosci. 2022 May-Jun;13(3):315-323. doi: 10.32598/bcn.2022.2090.1. Epub 2022 May 1.
PMID: 36457880 Free PMC article.
16.
Non-invasive brain stimulation therapy on neurological symptoms in patients with multiple sclerosis: A network meta analysis. Zhang X, Huai Y, Wei Z, Yang W, Xie Q, Yi L.
Front Neurol. 2022 Nov 15;13:1007702. doi: 10.3389/fneur.2022.1007702. eCollection 2022.
PMID: 36457862 Free PMC article. Review.
17.
Subjective cognitive impairment is related to work status in people with multiple sclerosis. van Wegen J, van Egmond EEA, Benedict RHB, Beenakker EAC, van Eijk JJJ, Frequin STFM, de Gans K, Gerlach OHH, van Gorp DAM, Hengstman GJD, Jongen PJ, van der Klink JJL, Reneman MF, Verhagen WIM, Middelkoop HAM, Visser LH, Hulst HE, van der Hiele K.
IBRO Neurosci Rep. 2022 Nov 2;13:513-522. doi: 10.1016/j.ibneur.2022.10.016. eCollection 2022 Dec.
PMID: 36457855 Free PMC article.
18.
Marchiafava Bignami Disease: A Rare Neurological Complication of Long-Term Alcohol Abuse. Singh S, Wagh V.
Cureus. 2022 Oct 30;14(10):e30863. doi: 10.7759/cureus.30863. eCollection 2022 Oct.
PMID: 36457608 Free PMC article. Review.
19.
[Acupuncture ameliorates neurological function by suppressing microglia polarization and inflammatory response after cerebral ischemia in rats]. Zhang HY, Zhao YJ, Zhang PJ, Guo MF, Yu JW, Chai Z, Ma CG, Song LJ, Yu JZ.
Zhen Ci Yan Jiu. 2022 Nov 25;47(11):941-48. doi: 10.13702/j.1000-0607.20210988.
PMID: 36453669 Chinese.
20.
Pathogenesis of (smoking-related) non-communicable diseases-Evidence for a common underlying pathophysiological pattern. Kopp W.
Front Physiol. 2022 Dec 15;13:1037750. doi: 10.3389/fphys.2022.1037750. eCollection 2022.
PMID: 36589440 Free PMC article. Review.